- Home
- ABUS vs SES Comparison
ABUS vs SES Comparison
Compare ABUS & SES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABUS | SES |
|---|---|---|
| Founded | 2005 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 888.5M | 719.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ABUS | SES |
|---|---|---|
| Price | $4.84 | $2.04 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $5.00 | $4.00 |
| AVG Volume (30 Days) | 1.4M | ★ 5.9M |
| Earning Date | 11-13-2025 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $14,606,000.00 | ★ $18,478,000.00 |
| Revenue This Year | $125.30 | $1,007.16 |
| Revenue Next Year | N/A | $131.04 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 116.64 | N/A |
| 52 Week Low | $2.71 | $0.38 |
| 52 Week High | $5.10 | $3.73 |
Technical Indicators
Market Signals| Indicator | ABUS | SES |
|---|---|---|
| Relative Strength Index (RSI) | 57.71 | 51.77 |
| Support Level | $4.65 | $1.77 |
| Resistance Level | $5.05 | $2.20 |
| Average True Range (ATR) | 0.22 | 0.14 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 67.46 | 62.79 |
Price Performance
Historical ComparisonAbout ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.
About SES SES AI Corporation
SES AI Corp is a developer and manufacturer of high-performance, AI-enhanced Lithium-Metal (Li-Metal) and Lithium-ion (Li-ion) rechargeable battery technologies for electric vehicles (EVs), Urban Air Mobility (UAM), drones, robotics, Battery Energy Storage Systems (BESS) and other applications. It includes Software and Hardware products that are EV, UAM, Drone, Molecular Universe, and Avatar.